FDA & Cardiovascular Care: Merck won FDA approval for Lipfendra, a first noninjectable PCSK9-blocking pill for patients who still need extra LDL lowering after statins, aiming to expand access beyond costly injections. Legal Accountability in Care: India’s Supreme Court sharply criticized private hospitals and police in a case alleging a 4-year-old rape victim was denied timely treatment for hours, spotlighting failures in emergency care. Health System Oversight: South Africa’s HPCSA said it will verify doctors’ medical certificates after the Madlanga Commission raised concerns about questionable notes submitted at the last minute. Medicaid Pressure: Minnesota extended a freeze on new Medicaid providers in 12 high-risk services as it revalidates thousands of providers to protect funding. Cancer Treatment Decisions: Mayo Clinic research found stopping lenalidomide maintenance after two years didn’t worsen survival for standard-risk multiple myeloma, potentially reducing long-term treatment burden. Affordability & Billing: Coverage highlighted how administrative complexity and Medicaid cuts are driving costs and limiting access, while the AHA pushed practical steps to lower patient cost-sharing and prior authorization barriers. Public Health & Safety: Uganda discharged its last Ebola patient, while the DRC remains the only country with active cases as the outbreak continues. Clinical Tech: STAT+ reported MDCalc is adding a quality-rating system for clinical calculators used by clinicians, addressing concerns about limited validation.